Your browser doesn't support javascript.
Repurposing mefenamic acid in the management of covid-19
Aggarwal, K. K.; Chong, Y. W.; Sharma, R.; Pillai, M.; Naidu, R.; Chan, A. Y. S.; Urabe, M. U.; Cavalcanti, D.; Budhathoky, P.; Sajjad, Q.; D’souza, R.; Ganabaskaran, N.; Chowdhary, M. J.; Prakash, Asokan, R. V.; Datta, R. K.; Alapet, J.; Goel, V. K.; Prakash, B.; Joshi, S.; Gupta, A.; Garg, S.; Thomas, A.; Rai, D. R.; Jayalal, J. A.; Arora, P. N.; Kalra, K.; Aggarwal, A. K.; Chakravarti, A.; Pandya, A.; Tripathi, S.; Mishra, B.; Jain, T. S.; Pachnekar, A.; Utture, S. S.; Mehta, K.; Pareek, R. P.; Nachane, A. P.; Gowda, A.; Karande, S..
Journal of the Indian Medical Association ; 119(1):16-23, 2021.
Article in English | EMBASE | ID: covidwho-1106848
ABSTRACT
With the growing understanding of coronavirus disease-2019 (COVID-19) pathogenesis, different therapeutic targets are being considered for the management of COVID-19. The development of new drugs is a time-consuming process;hence, many drugs acting on similar therapeutic targets/sites in the COVID-19 treatment are repurposed in COVID-19. In this article, an expert panel deliberated on the existing evidence on the immunopathogenesis, therapeutic targets under consideration for treatment of COVID-19, and the place of mefenamic acid in the therapy landscape of COVID-19. The expert panel has also provided recommendations regarding the dose and regimen of mefenamic acid in different phases of the COVID-19 disease.
Search on Google
Print
XML
Collection: Databases of international organizations Database: EMBASE Language: English Journal: Journal of the Indian Medical Association Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Search on Google
Print
XML
Collection: Databases of international organizations Database: EMBASE Language: English Journal: Journal of the Indian Medical Association Year: 2021 Document Type: Article